Dr. Manoj Luthra

Consult Dr. Manoj Luthra

Name:

Dr. Manoj Luthra

Hospital

Jaypee Hospital

Locations

Greater Noida (Delhi NCR)

Gender

Male

Languages Spoken

English, Hindi

About Dr. Manoj Luthra

Dr. Manoj Luthra’s Qualifications

MBBS, MS (General Surgery) and MCh (Cardiac Surgery)

Dr. Manoj Luthra’s Memberships

Pediatric Cardiac Society of India,
World Congress of Pediatric Cardiac Surgeons

Dr. Manoj Luthra’s Speciality

Adept at performing a wide range of cardiac surgeries (adult &amp

Dr. Manoj Luthra’s Previous Experience/Employment

Head of Dept of Cardiac Surgery at Army Hospital (R &amp

Dr. Manoj Luthra’s Research and Publications

PUBLICATIONS:
1. Unusual neurological syndrome of hyperkplexia. Rajasthan, 1993
2. Acute carbon monoxide poisoning leading to myocardial injury, motor ataxia, Journal of association physicians on india. 45: 408:1997.
3. Brain stem infarct : unusual neurological complication of cerebral malaria Journal of association physicians on india. 45: 408:1997
4. Electrocardiographic diagnosis of acute M.I.in left BBB : Current medical trends : 1997 :1: 111-112.
5. Primary extranodal non-hodgkins lymphoma in northern india : Proc Am Soc clin oncol.: 22: 611: 2003.
6. Testicular germ cell tumors: experience from a single centre in india: Proc Am Soc clin oncol :22: 422: 2003.
7. Imatinib mesylate in treatment of CML : Proc Am Soc clin oncol: 22: 221: 2003.
8. Oxaliplatin and folinic acid and 5-FU : A first line therapy in colorectal cancer: Oncology: 2002.
9. Long term outcome of hairy cell leukemia: experience from a IRCH. AIIMS.Oncology hematology . 2003.
10. Interferon induced lupus nephritis in patients of CML: March 2005 : 46:481-482.

Poster presentation
Novel and effective management of capecitabine induced hand foot syndrome : Proc Am Soc clin oncol: 23:751: 2004(Abstract 8105)

Research Activities
1. Clinical research associate in protocol 94CE 32 .Phase III comparative study of combination treatment with TLC D99 liposomal doxorubicin and cyclophosphamide and doxorubicin in metastatic breast cancer.
2. A Multicentric ,open label phase III clinical trial to evaluate the safety of filgrastim in cancer patients with grade 3 or 4 chemotherapy induced neutropenia.
3. Organizing secretary, 4th international seminar on psycosocial oncology, new delhi, april 1999.